Vor Biopharma Inc. (VOR)
NASDAQ: VOR · IEX Real-Time Price · USD
1.810
+0.010 (0.56%)
May 17, 2024, 4:00 PM EDT - Market closed
Vor Biopharma Stock Forecast
VOR's stock price has decreased by -59.87% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Vor Biopharma stock have an average target of 13.42, with a low estimate of 10 and a high estimate of 18. The average target predicts an increase of 641.44% from the current stock price of 1.81.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vor Biopharma stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 5 | 4 | 4 | 4 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +562.98% | May 13, 2024 |
Oppenheimer | Oppenheimer | Buy Reiterates $15 → $10 | Buy | Reiterates | $15 → $10 | +452.49% | May 13, 2024 |
Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +507.73% | May 10, 2024 |
Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +507.73% | Apr 23, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +562.98% | Mar 22, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.45
from -1.75
EPS Next Year
-1.31
from -1.45
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | 102.2M | 200.1M |
Avg | n/a | n/a | n/a | 33.1M | 107.4M |
Low | n/a | n/a | n/a | n/a | 9.3M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 505.3% |
Avg | - | - | - | - | 225.0% |
Low | - | - | - | - | -71.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.06 | -0.92 | -0.81 | -0.12 | 0.89 |
Avg | -1.45 | -1.31 | -1.24 | -0.98 | -0.48 |
Low | -1.76 | -1.58 | -1.52 | -1.55 | -1.22 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.